These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37759071)

  • 1. Correlation between tear levels of vascular endothelial growth factor and vitamin D at retinopathy of prematurity stages in preterm infants.
    Murugeswari P; Vinekar A; Prakalapakorn SG; Anandula VR; Subramani M; Vaidya TA; Nair AP; Jayadev C; Ghosh A; Kumaramanickavel G; Shetty R; Das D
    Sci Rep; 2023 Sep; 13(1):16175. PubMed ID: 37759071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear Fluid Angiogenic Factors: Potential Noninvasive Biomarkers for Retinopathy of Prematurity Screening in Preterm Infants.
    Vinekar A; Nair AP; Sinha S; Vaidya T; Chakrabarty K; Shetty R; Ghosh A; Sethu S
    Invest Ophthalmol Vis Sci; 2021 Mar; 62(3):2. PubMed ID: 33646290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between VEGF isoforms and impending retinopathy of prematurity.
    Movsas TZ; Muthusamy A
    Int J Dev Neurosci; 2020 Nov; 80(7):586-593. PubMed ID: 32737903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGF-A, VEGFR-1, VEGFR-2 and Tie2 levels in plasma of premature infants: relationship to retinopathy of prematurity.
    Pieh C; Agostini H; Buschbeck C; Krüger M; Schulte-Mönting J; Zirrgiebel U; Drevs J; Lagrèze WA
    Br J Ophthalmol; 2008 May; 92(5):689-93. PubMed ID: 18408080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of VEGF and IGF-1 plasma levels in preterm infants--potential correlation with retinopathy of prematurity, clinical implications].
    Machalińska A; Modrzejewska M; Dziedziejko V; Kotowski M; Safranow K; Herbowska A; Karczewicz D
    Klin Oczna; 2009; 111(10-12):302-6. PubMed ID: 20169883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of tear angiogenic factors in retinopathy of prematurity: a pilot biomarker study.
    Magnani JE; Omar Moinuddin ; Mercy Pawar ; Sathrasala S; McCaffery H; Vartanian RJ; Besirli CG
    J AAPOS; 2023 Feb; 27(1):14.e1-14.e6. PubMed ID: 36581150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between apelin and VEGF levels in retinopathy of prematurity: a matched case-control study.
    Zhang Y; Feng J; Shao S; Mu Q; Liu J; Zeng C; Zhang X
    BMC Ophthalmol; 2022 Aug; 22(1):342. PubMed ID: 35953806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockers for prevention and treatment of retinopathy of prematurity in preterm infants.
    Kaempfen S; Neumann RP; Jost K; Schulzke SM
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011893. PubMed ID: 29499081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of vascular endothelial growth factor in relation to retinopathy of prematurity.
    Hellgren G; Löfqvist C; Hård AL; Hansen-Pupp I; Gram M; Ley D; Smith LE; Hellström A
    Pediatr Res; 2016 Jan; 79(1-1):70-5. PubMed ID: 26372519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous levels of stromal cell-derived factor 1 and vascular endothelial growth factor in patients with retinopathy of prematurity.
    Sonmez K; Drenser KA; Capone A; Trese MT
    Ophthalmology; 2008 Jun; 115(6):1065-1070.e1. PubMed ID: 18031819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of VEGF/VEGF-receptor and HGF/c-Met promoter polymorphisms with progression/regression of retinopathy of prematurity.
    Kaya M; Çokakli M; Berk AT; Yaman A; Yesilirmak D; Kumral A; Atabey N
    Curr Eye Res; 2013 Jan; 38(1):137-42. PubMed ID: 23094709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.
    Barry GP; Yu Y; Ying GS; Tomlinson LA; Lajoie J; Fisher M; Binenbaum G;
    Ophthalmology; 2021 Aug; 128(8):1188-1196. PubMed ID: 33387554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms of Vascular Endothelial Growth Factor and Retinopathy of Prematurity.
    Ali AA; Hussien NF; Samy RM; Husseiny KA
    J Pediatr Ophthalmol Strabismus; 2015; 52(4):245-53. PubMed ID: 25992764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity.
    Sato T; Kusaka S; Shimojo H; Fujikado T
    Ophthalmology; 2009 Sep; 116(9):1599-603. PubMed ID: 19371954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity.
    Sato T; Kusaka S; Shimojo H; Fujikado T
    Ophthalmology; 2009 Nov; 116(11):2165-9. PubMed ID: 19700197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection and correlation of tear fluid inflammatory factors that influence angiogenesis in premature infants with and without retinopathy of prematurity.
    Vinekar A; Nair AP; Sinha S; Vaidya T; Shetty R; Ghosh A; Sethu S
    Indian J Ophthalmol; 2023 Nov; 71(11):3465-3472. PubMed ID: 37870008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Chandra P
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD009734. PubMed ID: 29308602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Serum Levels of Asymmetric Dimethylarginine, Vascular Endothelial Growth Factor, and Insulin-Like Growth Factor-1 in Preterms with Retinopathy of Prematurity.
    Aydoğan S; Dilli D; Kabataş EU; Akduman H; Şah Ipek M; Oğuz B; Ataş N; Zenciroğlu A
    Fetal Pediatr Pathol; 2022 Aug; 41(4):634-639. PubMed ID: 34289792
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.